According to a statement made recently by Eli Lilly, they have submitted a nasal glucagon treatment to the FDA. The treatment would be for cases of severe hypoglycemia in adults and children with diabetes. This treatment would be the first of it’s kind, a nasal spray, to treat low blood glucose emergencies in those with diabetes.  

“The submissions put us one step closer to bringing this innovative rescue medicine to the diabetes community and filling an important need in the treatment of severe hypoglycemia,” said Thomas Hardy, Senior Medical Director, Lilly Diabetes, told Endocrine Today. 

The way glucagon is currently administered can be a complicated process, requiring the administer to reconstitute the powder and other steps. This can be a confusing process, particularly if you are a caregiver a a child with diabetes. The new nasal glucagon would deliver the medicine in a powder form in an easy, ready to use format. Many people already understand how to use nose spray, making this functional but also realistic in a hypoglycemic emergency. 

 “This is important and different. You don’t want people to get low [blood sugar], but they do. It’s not a pretend problem, and the fact that the science is clear that people don’t know how to treat it makes it a real problem. With this nasal glucagon kit, anyone could rescue them.”

To learn more about the new nasal glucagon – Lilly submits NDA for nasal glucagon by Helio Endocrine Today